Canada Pension Plan Investment Board Altimmune, Inc. Transaction History

Canada Pension Plan Investment Board

  • $98.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$3.94 - $11.77 $717,080 - $2.14 Million
-182,000 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$5.9 - $9.45 $1.07 Million - $1.72 Million
182,000 New
182,000 $1.11 Million
Q4 2021

Feb 14, 2022
SELL
$8.69 - $12.48 $2.61 Million - $3.74 Million
-300,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$8.43 - $16.81 $2.53 Million - $5.04 Million
300,000 New
300,000 $3.39 Million

Others Institutions Holding ALT

# of Institutions
186
Shares Held
39.3M
Call Options Held
913K
Put Options Held
743K
View Full List

About Altimmune, Inc.

ALT Quotes by TradingView
  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $404M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email